US OptionsDetailed Quotes
CVAC250516C2000
- 1.00
- 0.000.00%
15min DelayTrading Apr 15 10:27 ET
0.00High0.00Low
0.00Open1.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV-12.41%PremiumMay 16, 2025Expiry Date1.43Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.43Leverage Ratio--Theta--Rho--Eff Leverage--Vega
CureVac Stock Discussion
CureVac Achieves Landmark Year: €535M Revenue, Profitable Operations, and Advancing Cancer Trials
CureVac's Revolutionary mRNA Cancer Treatment Gets FDA Green Light for Lung Cancer Trial
Major Patent Victory: CureVac's Critical mRNA Technology Upheld Against BioNTech Challenge
Benzinga· 23 mins ago
European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended formA hearing on infringement of EP 3 708 668 B1 is scheduled for July 1, 2025, before the Regional Court DüsseldorfConfirming validity of patent in its amended form marks major miles...
kinda bullish here.
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release
7. Remember, some stocks may get pumped WITHOUT any catalyst
8. NEVER be a blind follower.
LASTLY, If y...
$Aethlon Medical (AEMD.US)$
$BioCryst Pharmaceuticals (BCRX.US)$
$CureVac (CVAC.US)$
$GeoVax Labs (GOVX.US)$
$Inovio Pharmaceuticals (INO.US)$
$Nanoviricides (NNVC.US)$
$China SXT Pharmaceuticals (SXTC.US)$
$Virax Biolabs (VRAX.US)$
No comment yet